Blood Plasma Derivatives Industry Anticipated to Expand at 9.1% CAGR During the Forecast Period

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Forecasted Market Size Estimates For The Blood Plasma Derivatives Market Between 2025 And 2029?

The blood plasma derivatives market has demonstrated significant growth in recent years. It is projected to expand from $51.81 billion in 2024 to $55.76 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.6%. This historical growth can be attributed to several factors including the rising prevalence of hemophilia and bleeding disorders, an increase in the geriatric population, heightened awareness and diagnosis, a surge in surgical procedures, and global blood transfusion services.

The blood plasma derivatives market is projected to experience substantial expansion over the upcoming years. This market is forecast to reach a valuation of $79.09 billion by 2029, achieving a compound annual growth rate (CAGR) of 9.1%. Key factors driving this growth during the forecast period include the rise of therapies for rare diseases, the increasing prevalence of chronic conditions, escalating healthcare spending, personalized patient treatment methodologies, and improvements in healthcare infrastructure. Significant trends expected in the coming period encompass breakthroughs in fractionation technologies, tailored patient care strategies, strategic alliances and partnerships, broader applications within neurology, and continuous technological innovation in plasma fractionation.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12107&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Blood Plasma Derivatives Industry?

The expanding occurrence of immunodeficiency disorders is projected to propel the growth of the blood plasma derivatives market. Immunodeficiency disorders are conditions characterized by a partial or complete impairment of the immune system. Blood plasma derivatives serve as therapeutic agents for numerous medical ailments, prominently including immune deficiency disorders. Plasma, a solution rich in proteins and salts, contains more than 100 distinct proteins, with immunoglobulins being particularly valuable for managing primary immunodeficiencies. Furthermore, poor nutrition or malnutrition contributes to macro- and micronutrient deficiencies, which can lead to immunodeficiency. For instance, in March 2022, data from the Allergy, Asthma & Clinical Immunology indicated that Common Variable Immunodeficiency (CVID) was the most prevalent condition, affecting 16.6% of individuals in the US, 12.9% internationally, and 13.9% worldwide. Consequently, the increasing prevalence of immune deficiency disorders is a significant catalyst for the expansion of the blood plasma derivatives market.

What Are The Key Segments In The Blood Plasma Derivatives Market?

The blood plasma derivativesmarket covered in this report is segmented –

1) By Type: Albumin; Factor VIII; Factor IX; Immunoglobulin; Hyperimmune Globulin; Other Types

2) By Application: Hemophilia; Hypogammaglobulinemia; Immunodeficiency Diseases; Von Willebrand’s Disease; Other Applications

3) By End-User: Hospitals; Clinics; Other End-Users

Subsegments:

1) By Albumin: Human Serum Albumin; Recombinant Albumin

2) By Factor VIII: Plasma-Derived Factor VIII; Recombinant Factor VIII

3) By Factor IX: Plasma-Derived Factor IX; Recombinant Factor IX

4) By Immunoglobulin: Intravenous Immunoglobulin (IVIG); Subcutaneous Immunoglobulin (SCIG)

5) By Hyperimmune Globulin: Specific Pathogen-Reduced Hyperimmune Globulin; Standard Hyperimmune Globulin

6) By Other Types: Fibrinogen; Clotting Factor Concentrates; Plasma-Derived Proteins

How Are Trends Influencing The Blood Plasma Derivatives Market?

Leading companies within the blood plasma derivatives market are concentrating on forging strategic partnerships to gain a competitive advantage. Through such collaborations, patients in need will gain access to a consistent and reliable provision of these critical plasma-derived medications, thereby helping to address the escalating demand for immunoglobulins in France and beyond. For instance, in January 2022, Kedrion S.p.A., an Italy-based biopharmaceutical company specializing in the development, production, and distribution of plasma-derived therapies, entered into a partnership with LPB, a UK-based pharmaceutical company focused on biological medicinal products. Kedrion plans to process LFB plasma, sourced in France by the Etablissement Français du Sang (EFS), to manufacture immunoglobulins in Hungary. These imports from LFB in France are set to supplement the existing supply of immunoglobulins, which will be made accessible to hospitals throughout the nation under the direction and oversight of French health authorities.

Who Are The Core Companies Influencing The Blood Plasma Derivatives Market Landscape?

Major companies operating in the blood plasma derivatives market include Bayer AG, Sanofi S.A., Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Meiji Group, Grifols S.A., Shire Pharmaceuticals Inc., GC Biopharma Corp, Emergent BioSolutions Inc., Shanghai Raas Blood Products Co Ltd., Kedrion S.p.A., Sanquin, Biotest AG, Bio Products Ltd., ADMA Biologics Inc., China Biologic Products Holdings Inc., BioIVT, PlasmaGen BioSciences Pvt. Ltd., Virchow Biotech Private Limited, LFB S.A., Intas Pharmaceuticals Ltd., Octapharma Plasma

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

Which Geographies Are Emerging As Strong Markets For The Blood Plasma Derivatives Industry?

North America was the largest region in the blood plasma derivatives market in 2024. The regions covered in the blood plasma derivatives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Blood Plasma Derivatives Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12107&type=smp

Browse Through More Reports Similar to the Global Blood Plasma Derivatives Market 2025, By The Business Research Company

Blood Transfusion Diagnostics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report

Blood Glucose Meters Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report

Blood And Blood Components Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blood-and-blood-components-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795